Genomic Red Flags: HLA’s Impact on Drug Safety Recorded Presentation
Join this discussion on HLA-associated adverse drug reactions, an emerging consideration when prescribing high-risk medications. Titled “Genomic Red Flags: HLA’s Impact on Drug Safety,” this presentation will explore the classifications of adverse drug reactions, the essential role of HLA polymorphic genes in the human body, and the various drug-HLA associations. It will also explore approaches to diagnosis, management, and the growing importance of HLA screening as a preventative strategy shaping the future of healthcare. Highlighting emerging research, the presentation will underscore how preemptive HLA testing can significantly enhance patient outcomes for those at risk of HLA-associated adverse drug reactions.
If you attended Genomic Red Flags: HLA’s Impact on Drug Safety on March 27, 2025, you will not be able to claim credit again for this course. However, you are welcome to still watch the content.
Target Audience
This course is intended for Advocate Pharmacists, Physicians, Nurses, and other interested healthcare professionals
Learning Objectives
At the end of this session, learners should be able to:
- Identify the history and function of Human Leukocyte Antigen (HLA) and the effect they have on the human body
- Differentiate the classification of different adverse drug reactions
- Assess HLA screening for high-risk medications and the role it plays in the patient care process
- Recall specific medications and their adverse drug reactions in patients with atypical HLA genes
Faculty
Cassandra Caringella, PharmD, PGY1 Pharmacy Resident – Advocate Lutheran General Hospital
Disclosure
The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose.

Accreditation Statement
In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Statement(s)
American Medical Association (AMA)
Advocate Health designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Advocate Health designates this enduring activity for a maximum of 1.00 ANCC contact hours/APRN pharmacological hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Council for Pharmacy Education (ACPE)
Advocate Health designates this enduring activity for a maximum 1.00 hours of CPE credit for (pharmacists and pharmacy technicians). CPE credit can be claimed on the AAH CE platform within 60 days of activity completion and information will be provided to CPE Monitor. Participants should only claim credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 1.00 AttendanceAttendance Credit
- 1.00 Approved AMA PRA Category 1 Credit™
- 1.00 Continuing Nursing Education (CE)Aurora Health Care is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 1.00 contact hours have been awarded to this activity by the Wisconsin Nursing Association. To receive contact hours, participants must attend the entire activity.
- 1.00 Continuing Pharmacy Education (CPE)Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Price
If you attended Genomic Red Flags: HLA’s Impact on Drug Safety on March 27, 2025, you will not be able to claim credit again for this course. However, you are welcome to still watch the content.
This course is available to Advocate Aurora providers (employed and independent) and caregivers only. Click “Take Course” to register for this program.
If you have any questions, please contact the IPCE Office at [email protected]

Facebook
X
LinkedIn
Forward